| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Salicylic acid 60 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Salicylic acid 110 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| salicylsyragel | Has manufactured dose form | False | Cutaneous gel | Inferred relationship | Some |  | 
| bensoylperoxid 100 mikrogram/milligram, kutan gel | Has manufactured dose form | False | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| metronidazol, gel | Has manufactured dose form | False | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Metronidazole 10 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Tetracaine hydrochloride 20 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| bensoylperoxid 2,5 % + klindamycin 1,2 %, gel för lokalt bruk | Has manufactured dose form | False | Cutaneous gel | Inferred relationship | Some |  | 
| klindamycin 1,2 % / tretinoin 0,025 %, gel för lokalt bruk | Has manufactured dose form | False | Cutaneous gel | Inferred relationship | Some |  | 
| Polynoxylin 100 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Adapalene 3 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Adapalene 1 mg/g and benzoyl peroxide 25 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Diclofenac sodium 30 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Ibuprofen 50 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely ketoprofen 25 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely piroxicam 5 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Ibuprofen 100 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Fluocinolone acetonide 250 microgram/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Tretinoin 100 microgram/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely nicotinamide 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Lidocaine hydrochloride 5 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Lidocaine hydrochloride 10 mg/mL cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| adapalen 1 mikrogram/milligram, kutan gel | Has manufactured dose form | False | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely becaplermin 100 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Desoximetasone 500 microgram/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| testosteron 1 %, gel | Has manufactured dose form | False | Cutaneous gel | Inferred relationship | Some |  | 
| Tretinoin 1 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| deoximetason 0,5 %, gel | Has manufactured dose form | False | Cutaneous gel | Inferred relationship | Some |  | 
| Fluocinonide 500 microgram/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| betametasondipropionat 0,05 %, gel | Has manufactured dose form | False | Cutaneous gel | Inferred relationship | Some |  | 
| Clobetasol propionate 500 microgram/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely ibuprofen 50 milligram/1 gram and levomenthol 30 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| testosteron 50 mg, gel 5 g, dospåse | Has manufactured dose form | False | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely benzoyl peroxide 50 milligram/1 gram and clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| terbinafinhydroklorid 1 %, gel | Has manufactured dose form | False | Cutaneous gel | Inferred relationship | Some |  | 
| Tretinoin 400 microgram/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Lidocaine hydrochloride 20 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Azelaic acid 150 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Dapsone 50 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Desonide 500 microgram/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Ketoconazole 20 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Oxybutynin hydrochloride 100 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely tazarotene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely benzoyl peroxide 25 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely dithranol 2.5 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Coal tar 50 mg/g and pine tar 50 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Tazarotene 500 microgram/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Diclofenac diethylammonium 11.6 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Estradiol 600 microgram/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Testosterone 10 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Terbinafine (as terbinafine hydrochloride) 10 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely chlorhexidine (as chlorhexidine gluconate) 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely silver nanoparticle 20 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Diclofenac sodium 10 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely testosterone 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Testosterone 16.2 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely estradiol 1 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Diclofenac sodium (as diclofenac diethylammonium) 20 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Carbenoxolone 20 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely etofenamate 50 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Brimonidine (as brimonidine tartrate) 3.3 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Diclofenac sodium (as diclofenac diethylammonium) 10 mg/g cutaneous gel | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  | 
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | True | Cutaneous gel | Inferred relationship | Some |  |